[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1055963A1 - Valsartan salts - Google Patents

Valsartan salts Download PDF

Info

Publication number
HK1055963A1
HK1055963A1 HK03108267.6A HK03108267A HK1055963A1 HK 1055963 A1 HK1055963 A1 HK 1055963A1 HK 03108267 A HK03108267 A HK 03108267A HK 1055963 A1 HK1055963 A1 HK 1055963A1
Authority
HK
Hong Kong
Prior art keywords
salt
water
pharmaceutically acceptable
valsartan
acceptable salt
Prior art date
Application number
HK03108267.6A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1055963B (en
Inventor
Erwin Marti
Hans Rudolf Oswald
Peter Bühlmayer
Wolfgang Marterer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8169294&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1055963(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1055963A1 publication Critical patent/HK1055963A1/en
Publication of HK1055963B publication Critical patent/HK1055963B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HK03108267.6A 2000-07-19 2001-07-17 Valsartan salts HK1055963B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00115556.3 2000-07-19
EP00115556 2000-07-19
PCT/EP2001/008253 WO2002006253A1 (en) 2000-07-19 2001-07-17 Valsartan salts

Publications (2)

Publication Number Publication Date
HK1055963A1 true HK1055963A1 (en) 2004-01-30
HK1055963B HK1055963B (en) 2009-05-22

Family

ID=

Also Published As

Publication number Publication date
CY1108559T1 (el) 2014-04-09
KR20030015888A (ko) 2003-02-25
BR0112665A (pt) 2003-06-24
CN1443176A (zh) 2003-09-17
MXPA03000525A (es) 2003-05-14
EP1313714A1 (en) 2003-05-28
ATE406355T1 (de) 2008-09-15
CZ2003117A3 (cs) 2003-05-14
DE60135560D1 (de) 2008-10-09
RU2275363C2 (ru) 2006-04-27
SI1313714T1 (sl) 2009-02-28
JP2004504307A (ja) 2004-02-12
WO2002006253A1 (en) 2002-01-24
US8278339B2 (en) 2012-10-02
HUP0300731A3 (en) 2006-05-29
KR100529658B1 (ko) 2005-11-21
IL153882A (en) 2009-09-01
SK287558B6 (sk) 2011-02-04
JP4102664B2 (ja) 2008-06-18
ECSP034436A (es) 2003-03-10
PL205715B1 (pl) 2010-05-31
CN100413852C (zh) 2008-08-27
NO326504B1 (no) 2008-12-15
EP1313714B1 (en) 2008-08-27
HUP0300731A2 (hu) 2003-09-29
HU229280B1 (en) 2013-10-28
AR069374A2 (es) 2010-01-20
MY152846A (en) 2014-11-28
US9499499B2 (en) 2016-11-22
PE20020613A1 (es) 2002-08-07
US20120329844A1 (en) 2012-12-27
PT1313714E (pt) 2008-11-03
CA2415962A1 (en) 2002-01-24
US20070149587A1 (en) 2007-06-28
DK1313714T3 (da) 2008-12-15
CZ303389B6 (cs) 2012-08-29
NO20030232D0 (no) 2003-01-17
CN1680341A (zh) 2005-10-12
AR032758A1 (es) 2003-11-26
PL360737A1 (en) 2004-09-20
US20080293791A1 (en) 2008-11-27
NZ523557A (en) 2004-12-24
NO20030232L (no) 2003-01-17
US20140073677A1 (en) 2014-03-13
SK552003A3 (en) 2003-07-01
ZA200300285B (en) 2004-03-25
CN1216873C (zh) 2005-08-31
MY136446A (en) 2008-10-31
ES2309090T3 (es) 2008-12-16
CA2415962C (en) 2010-07-06
AU2001289672B2 (en) 2005-12-08
US20030207930A1 (en) 2003-11-06
IL153882A0 (en) 2003-07-31
AU8967201A (en) 2002-01-30

Similar Documents

Publication Publication Date Title
EP1313714B1 (en) Valsartan salts
US8329919B2 (en) Salt hydrates
AU2001289672A1 (en) Valsartan salts
HK1055963B (en) Valsartan salts
AU2009201898B2 (en) Valsartan salts
HK1139681B (en) Salts of valsartan
AU2007205815A1 (en) Salts of valsartan

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140717